APP and early-onset autosomal dominant Alzheimer disease: Lifelong choline supplementation in another Alzheimer’s disease mouse model (APP/PS1 transgenic mice), significantly diminished amyloid-β plaque load and decreased activated microglia, thereby mitigating the detrimental effects of brain inflammation associated with Alzheimer’s disease (44).